PRELID2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.081980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.794000E-02
Normal-vs-Stage2
9.402300E-02
Normal-vs-Stage3
2.358400E-01
Normal-vs-Stage4
3.457600E-02
Stage1-vs-Stage2
4.675000E-01
Stage1-vs-Stage3
9.853400E-01
Stage1-vs-Stage4
7.014800E-01
Stage2-vs-Stage3
5.429200E-01
Stage2-vs-Stage4
7.377200E-01
Stage3-vs-Stage4
7.736400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.009800E-02
Normal-vs-AfricanAmerican
1.536600E-01
Normal-vs-Asian
2.765700E-02
Caucasian-vs-AfricanAmerican
5.060600E-01
Caucasian-vs-Asian
2.582800E-01
AfricanAmerican-vs-Asian
1.641150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.551900E-02
Normal-vs-Female
1.521560E-01
Male-vs-Female
5.548200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.128800E-01
Normal-vs-Age(41-60Yrs)
9.767700E-02
Normal-vs-Age(61-80Yrs)
1.169650E-01
Normal-vs-Age(81-100Yrs)
1.327760E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.133200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.192400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.255000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.576000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.603000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.897000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.633600E-04
Normal-vs-Daily Drinker
7.203600E-02
Normal-vs-Weekly Drinker
1.642050E-01
Normal-vs-Occasional Drinker
8.398400E-02
Normal-vs-Social Drinker
1.026230E-01
Non Drinker-vs-Daily Drinker
3.241200E-01
Non Drinker-vs-Weekly Drinker
1.315410E-01
Non Drinker-vs-Occasional Drinker
1.381650E-01
Non Drinker-vs-Social Drinker
7.446200E-02
Daily Drinker-vs-Weekly Drinker
4.578600E-01
Daily Drinker-vs-Occasional Drinker
5.311400E-01
Daily Drinker-vs-Social Drinker
3.215000E-01
Weekly Drinker-vs-Occasional Drinker
8.386400E-01
Weekly Drinker-vs-Social Drinker
8.709800E-01
Occasional Drinker-vs-Social Drinker
6.770600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.344820E-01
Normal-vs-Grade 2
5.804300E-02
Normal-vs-Grade 3
3.839900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.633850E-02
Grade 1-vs-Grade 3
6.357500E-03
Grade 1-vs-Grade 4
1.344820E-01
Grade 2-vs-Grade 3
5.556800E-01
Grade 2-vs-Grade 4
5.804300E-02
Grade 3-vs-Grade 4
3.839900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.742960E-01
Normal-vs-NonDiabetic
9.526000E-02
Diabetic-vs-NonDiabetic
3.684800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.109640E-02
Normal-vs-NoPancreatitis
9.416300E-02
Pancreatitis-vs-NoPancreatitis
1.728160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.867600E-01
Normal-vs-N1
6.888000E-02
N0-vs-N1
6.313800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.144100E-02
Normal-vs-TP53-NonMutant
2.644800E-01
TP53-Mutant-vs-TP53-NonMutant
4.596300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
